Nexgel Inc
nexgel.comWhat Do They Do?
Sells branded health, skin-care and beauty products to consumers, and makes gel materials and finished products for healthcare companies and other brands.
10-K for FY2025, filed Mar 31, 2026We were incorporated in Delaware on January 13, 2009. We manufacture high water content, electron beam cross-linked, aqueous polymer…View ↗
Our branded consumer products are marketed under a diverse portfolio of brands, including our Medagel family of products (SilverSeal…View ↗
We are leveraging our hydrogel products and technologies by allowing other OTC brands to incorporate them into their products. We believe…View ↗
2025 2024 Year Ended December 31, 2025 2024 Contract manufacturing $ 3,657 $ 2,841 Custom and white label finished goods manufacturing 27…View ↗
How Do They Make Money?
Healthcare companies buy hydrogel rolls or finished custom goods and generally pay after shipment; consumers buy branded goods and pay when completing an online or retail purchase. The company earns revenue on business orders when customers receive the goods and on branded orders when the goods ship.
10-K for FY2025, filed Mar 31, 2026The Company currently recognizes revenue predominately from three sources: contract manufacturing, custom and white label finished goods…View ↗
The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are predominately concentrated in…View ↗
Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods.…View ↗
These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe…View ↗
These products are finished goods marketed and sold directly to consumers by the Company through online and retail channels. We are…View ↗
$11.4M
-
10-K for FY2025, filed Mar 31, 2026
$11.4M ↗
Who Are Their Customers?
Life sciences companies buy gel rolls and custom finished products; consumers buy branded goods through the company’s direct-to-consumer websites and online marketplaces, retail partners, and medical offices.
10-K for FY2025, filed Mar 31, 2026Our branded consumer products are marketed under a diverse portfolio of brands, including our Medagel family of products (SilverSeal…View ↗
The Company’s customers consist of other life sciences companies and Amazon retail customers. Revenues are predominately concentrated in…View ↗
Customers order rolls of gel (“rollstock”). The rollstock is shipped to our customers, which they package into finished goods.…View ↗
These products often infuse various ingredients into our base gel to develop unique product offerings to satisfy market demand (e.g. aloe…View ↗
These products are finished goods marketed and sold directly to consumers by the Company through online and retail channels. We are…View ↗
Do Revenues Turn Into Profits?
No. It lost $3M in FY2025.
10-K for FY2025, filed Mar 31, 2026
−$3.4MView ↗
10-K for FY2025, filed Mar 31, 2026
−$3MView ↗
10-K for FY2025, filed Mar 31, 2026
−$1.4MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 17, 2026
−$3.6MView ↗
- ▲ +447% (Loss)
- vs −$665K in Q2 FY2025
-
Aug 21, 2026
CEO departs; interim CEO appointed as board launches strategic review
The board formed a committee to review operations, assets, liquidity and strategy, including possible sales, partnerships, restructuring or wind-downs.
Sources
8-K, filed Aug 21, 2026
Effective August 21, 2026 (the “Separation Date”), NexGel, Inc. (the “Company”) terminated Adam R. Levy’s employment as Chief Executive…View ↗
-
May 12, 2026
Acquires Celularity assets and licenses
The acquisition involved assets and licenses from Celularity’s degenerative disease segment.
Sources
8-K, filed May 12, 2026
As previously disclosed in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on…View ↗
Growing. Revenue grew 7.4x in 4 years, from $1.6M in FY2021 to $11.4M in FY2025, about 65% a year.
Who Do They Compete With?
Competes with Johnson & Johnson, Pfizer Consumer Healthcare, Procter & Gamble, and 3M Healthcare
10-K for FY2025, filed Mar 31, 2026Consumer Products and Medical Devices. As we expand our consumer products and medical device business, we will face a number of…View ↗
Loading...
